Enhancement of brain activation during trial-and-error sequence learning in early PD

Neurology

Volumn 60, Issue 4, 2003, Pages 612-619

  Mentis, M J ^a,c   Dhawan, V ^a   Nakamura, T ^a   Ghilardi, M F ^b   Feigin, A ^a   Edwards, C ^a   Ghez, C ^b   Eidelberg, D ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

^b Columbia Coll of Phys and Surgeons ^*  (United States)

^c N Shore Long Isl Jewish Res Inst ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN FUNCTION; CEREBELLUM; CLINICAL ARTICLE; FEMALE; FRONTAL LOBE; HUMAN; LEARNING; LEARNING DISORDER; MALE; MOVEMENT (PHYSIOLOGY); PARIETAL LOBE; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PREMOTOR CORTEX; PRIORITY JOURNAL; TASK PERFORMANCE;

EID: 0037465534     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000044154.92143.DC     Document Type: Article

References (38)

1. Aarsland D, Tandberg E, Larsen JP, Cummings JL. Frequency of dementia in Parkinson disease, Arch Neurol 1996;53:538-542.
2. Pirozzolo FJ, Hansch EC, Mortimer JA, Webster DD, Kuskowski MA. Dementia in Parkinson disease: a neuropsychological analysis. Brain Cogn 1982;1:71-83.
3. Folstein MF, Folstein SE, McHugh PR. "Mini Mental State' - a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
4. Fahn S, Elton R, Committee tUD. Unified Parkinson Disease Rating Scale. In: Fahn S, Marsden C, Calne D, Goldstein M, eds. Recent developments in Parkinson's disease. New York: Macmillan, 1984;293-304.
5. Ghilardi M, Ghez C, Dhawan V, et al. Patterns of regional brain activation associated with different forms of motor learning. Brain Res 2000;871:127-145.
6. Jahanshahi M, Jenkins IH, Brown RG, Marsden CD, Passingham RE, Brooks DJ. Self-initiated versus externally triggered movements. I. An investigation using measurement of regional cerebral blood flow with PET and movement-related potentials in normal and Parkinson's disease subjects [see comments]. Brain 1995;118:913-933.
7. Ghez C, Favilla M, Ghilardi MF, Gordon J, Bermejo R, Pullman S. Discrete and continuous planning of hand movements and isometric force trajectories. Exp Brain Res 1997;115:217-233.
8. Dhawan V, Kazumata K, Robeson W, et al. Quantitative brain PET: comparison of 2D and 3D acquisition on the GE Advance Scanner. Clinical Positron Imaging 1998;1:135-144.
9. Silberswieg DA, Stern E, Frith CD, et al. Detection of thirty-second cognitive activations in single subjects with positron emission tomography: a new low-dose H2(15)O regional cerebral blood flow three-dimensional imaging technique. J Cereb Blood Flow Metab 1993;13:617-629.
10. Nakamura T, Ghilardi MF, Mentis M, et al. Functional networks in motor sequence learning: abnormal topographies in Parkinson's disease. Hum Brain Mapp 2001;12:42-60.
11. Friston KJ. Human brain function. New York: Academic Press, 1997.
12. Grafton ST, Hazeltine E, Ivry R. Functional mapping of sequence learning in normal humans. J Cogn Neurosci 1995;7:479-510.
13. Jenkins IH, Brooks DJ, Nixon PD, Frackowiak RSJ, Passingham RE. Motor sequence learning: a study with positron emission tomography. J Neurosci 1994;14:3775-3790.
14. Boecker H, Dagher A, Ceballos-Baumann AO, et al. Role of the human rostral supplementary motor area and the basal ganglia in motor sequence control: investigations with H2 150 PET. J Neurophysiol 1998;79:1070-1080.
15. Honda M, Deiber M-P, Ibanez V, Pascual-Leone A, Zhuang P, Hallet M. Dynamic cortical involvement in implicit and explicit motor sequence learning: a PET study. Brain 1998;121:2159-2173.
16. Brown RG, Marsden CD. Cognitive function in Parkinson's disease: from description to theory. Trends Neurosci 1990;13:21-29.
17. Smith MC, Goldman WP, Janer KW, Baty JD, Morris JC. Cognitive speed in nondemented Parkinson's disease. J Int Neuropsychol Soc 1998;4:584-592.
18. Frith CD, Bloxham CA, Carpenter KN. Impairments in the learning and performance of a new manual skill in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1986;49:661-668.
19. Pate DS, Margolin DI. Cognitive slowing in Parkinson's and Alzheimer's patients: distinguishing bradyphrenia from dementia. Neurology 1994;44:669-674.
20. Rauch SL, Savage CR, Brown HD, et al. A PET investigation of implicit and explicit sequence learning. Hum Brain Mapp 1995;3:271-286.
21. Sakai K, Hikosaka O, Miyauchi S, Takino R, Sasaki Y, Putz B. Transition of brain activation from frontal to parietal areas in visuomotor sequence learning. J Neurosci 1998;18:1827-1840.
22. Toni I, Krams M, Turner R, Passingham RE. The time course of changes during motor sequence learning: a whole-brain fMRI study. Neuroimage 1998;8:50-61.
23. Buckner RL, Corbetta M, Schatz J, Raichle ME, Petersen SE. Preserved speech abilities and compensation following prefrontal damage. Proc Natl Acad Sci 1996;93:1249-1253.
24. Dubois B, Pillon B. Cognitive deficits in Parkinson's disease. J Neurol 1997;244:2-8.
25. Brown RG. The role of cortico-striatal circuits in learning sequential information. In: Stern GM, ed. Parkinson's disease: advances in neurology. Philadelphia: Lippincott Williams & Wilkins, 1999;31-39.
26. Doyon J, Laforrce R, Bouchard G, et al. Role of the striatum, cerebellum and frontal lobes in the automatization of a repeated visuomotor sequence of movements. Neuropsychologia 1998;36:625-641.
27. Alexander GE, Crutcher MD, DeLong MR. Basal gangliathalamocortical circuits: parallel substrates for motor, oculomotor, "prefrontal" and "limbic" functions. Prog Brain Res 1990;85:119-146.
28. Owen AM, Doyon J, Dagher A, Sadikot A, Evans AC. Abnormal basal ganglia outflow in Parkinson's disease identified with PET. Implication for higher cortical functions. Brain 1998;121:949-965.
29. Mentis MJ, McIntosh AR, Perrine K, et al. Relationships among the metabolic patterns that correlate with mnemonic, visuospatial, and mood symptoms in Parkinson's Disease. Am J Psychiatry 2002;159:746-754.
30. Pillon B, Dubois B, Cusimano G, Bonnet AM, Lhermitte F, Agid Y. Does cognitive impairment in Parkinson's disease result from nondopaminergic lesions? J Neurol Neurosurg Psychiatry 1989;52:201-206.
31. Cooper JC, Sagar HJ, Doherty SM, Jordan NJ, Tidswell P, Sullivan EV. Different effects of dopaminergic and anticholinergic therapies on cognitive and motor function in Parkinson's disease; a follow-up study of untreated patients. Brain 1992;115:1701-1725.
32. Malapani C, Pillon B, Dubois B, Agid Y. Impaired simultaneous cognitive task performance in Parkinson's disease: a dopamine-related dysfunction. Neurology 1994;44:319-326.
33. Mattay VS, Tessitore A, Callicott JH, et al. Dopaminergic modulation of cortical function in patients with Parkinson's disease. Ann Neurol 2002;51:156-164.
34. Scatton B, Javoy-Agid F, Rouqier L, Dubois B, Agid Y. Reduction of cortical dopamine, noradrenaline serotonin and their metabolites in Parkinson's disease. Brain Res 1983;275:321-328.
35. Mayeux R, Stern Y, Sano M, Williams JB, Cote LJ. The relationship of serotonin to depression in Parkinson's disease. Mov Disord 1988;3:237-244.
36. Perry EK, Curtis M, Dick DJ, et al. Cholinergic correlates of cognitive impairment in Parkinson's disease: comparisons with Alzheimer's disease. J Neurol Neurosurg Psychiatry 1985;48:413-421.
37. Mentis MJ, Sunderland T, Lai J, et al. Muscarinic versus nicotinic modulation of a visual task. A PET study using drug probes. Neuropsychopharmacology 2001;25:555-564.
38. Talairach J, Tournoux P. Co-planar stereotaxic atlas of the human brain. New York: Thieme Medical Publishers, 1988.